Steven J. Mento is Director at SANGAMO THERAPEUTICS, INC (SGMO). They have made 6 open-market trades across 2 companies since 2007, most recently 2020-05-22.
CIK 0001324466
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $152K since 2013, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SGMO | SELL | 2018-04-02 | 2018-04-04 | $18.39 | $264K | -6.8% | -14.8% | -20.3% |
| SGMO | SELL | 2018-03-01 | 2018-03-05 | $23.27 | $439K | -0.2% | -22.2% | -33.3% |
| SGMO | SELL | 2018-02-01 | 2018-02-05 | $20.59 | $474K | +27.4% | +42.9% | -10.0% |
| SGMO | SELL · 10b5-1 | 2015-03-05 | 2015-03-06 | $18.30 | $119K | -31.7% | +0.3% | +0.3% |
| SGMO | SELL · 10b5-1 | 2014-12-11 | 2014-12-15 | $15.00 | $95K | -31.7% | +0.3% | +0.3% |
| SGMO | SELL · 10b5-1 | 2014-06-09 | 2014-06-11 | $15.00 | $65K | -31.7% | +0.3% | +0.3% |
| SGMO | SELL · 10b5-1 | 2014-03-14 | 2014-03-17 | $22.77 | $139K | -31.7% | +0.3% | +0.3% |
| CNAT | BUY | 2013-07-30 | 2013-08-01 | $11.00 | $152K | N/A | N/A | N/A |
| SGMO | SELL | 2007-11-15 | 2007-11-19 | $14.75 | $221K | -31.7% | +0.3% | +0.3% |
| SGMO | SELL | 2007-11-14 | 2007-11-16 | $14.85 | $290K | -31.7% | +0.3% | +0.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.